Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.39 |
| ▸ | PPARG | P37231 | 6/20 | 0.39 |
| ▸ | PPARD | Q03181 | 6/20 | 0.39 |
| ▸ | PPARA | Q07869 | 6/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL915377 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL21876923 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL17908913 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL29016026 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL23191004 | 0.93 | ALDH1A1 (0.72) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL30008420 | 0.93 | ALDH1A1 (0.72) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL5355625 | 0.93 | ALDH1A1 (0.72) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL30008592 | 0.93 | ALDH1A1 (0.72) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| SCHEMBL5351480 | 0.93 | ALDH1A1 (0.72) | ALDH1A1TSHRLMNASLC22A6NFKB1 | |
| Adipic Acid SCHEMBL4805967 | 0.93 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNASLC22A6NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651698-B1 | ISOCYANATE-FREE PRIMER COMPOSITION FOR GLASS AND GLASS CERAMICS | SIKA TECHNOLOGY AG (CH) | 2012-09-12 | — | — | EP | claimed |
| EP-1651698-A1 | ISOCYANATE-FREE PRIMER COMPOSITION FOR GLASS AND GLASS CERAMICS | Sika Technology AG (CH) | 2006-05-03 | — | — | EP | claimed |
| WO-2005012382-A1 | ISOCYANATE-FREE PRIMER COMPOSITION FOR GLASS AND GLASS CERAMICS | SIKA TECHNOLOGY AG (CH) | 2005-02-10 | — | — | WO | claimed |
| EP-1502927-A1 | Isocyanate free primer composition for glass and glass-ceramics | Sika Technology AG (CH) | 2005-02-02 | — | — | EP | claimed |
| EP-4216946-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-116437913-A | Pharmaceutical compounds for treating complement-mediated disorders | 艾其林医药公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-115702234-A | Environment-friendly solvent, and washing composition and washing device comprising same | 株式会社LG生活健康 | 2023-02-14 | — | — | CN | disclosed |
| US-20220185785-A1 | INHIBITORS OF CD40-CD154 BINDING | TONIX Pharmaceuticals Holding Corp (US) | 2022-06-16 | — | — | US | disclosed |
| WO-2022066774-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| EP-3952853-A1 | INHIBITORS OF CD40-CD154 BINDING | Tonix Pharmaceuticals Holding Corp. (US) | 2022-02-16 | — | — | EP | disclosed |
| WO-2020210831-A1 | INHIBITORS OF CD40-CD154 BINDING | TONIX Pharmaceuticals Holding Corp (US) | 2020-10-15 | — | — | WO | disclosed |
| EP-3048093-B1 | ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF | MORESCO CORP (JP) | 2019-02-20 | — | — | EP | disclosed |
| US-20080318018-A1 | Black Resin Composition for Display Device, and Member for Display Device | DAI NIPPON PRINTING CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| WO-2008133896-A2 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| US-20070043196-A1 | Isocyanate-free primer composition for glass and glass ceramics | SIKA TECHNOLOGY AG (CH) | 2007-02-22 | — | — | US | disclosed |
| EP-1502927-A1 | Isocyanate free primer composition for glass and glass-ceramics | Sika Technology AG (CH) | 2005-02-02 | — | — | EP | disclosed |
| EP-0950078-B1 | PERFLUOROETHER-CONTAINING FLUOROELASTOMERS WITH GOOD LOW TEMPERATURE CHARACTERISTICS | DYNEON LLC (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-0950078-A1 | PERFLUOROETHER-CONTAINING FLUOROELASTOMERS WITH GOOD LOW TEMPERATURE CHARACTERISTICS | DYNEON LLC (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5891965-A | CURABLE COMPOSITION | DYNEON LLC (US) | 1999-04-06 | — | — | US | disclosed |
| WO-1998030631-A1 | PERFLUOROETHER-CONTAINING FLUOROELASTOMERS WITH GOOD LOW TEMPERATURE CHARACTERISTICS | DYNEON LLC (US) | 1998-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185785-A1 | INHIBITORS OF CD40-CD154 BINDING | CD40LG, CD40, CD4 | ALDH1A1 1606/4885TSHR 908/4885LMNA 3791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.